FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016063327> ?p ?o ?g. }

• W2016063327 endingPage "31" @default.
• W2016063327 startingPage "19" @default.
• W2016063327 abstract "Low-density lipoprotein cholesterol (LDL-C) reduction with statins is the cornerstone of atherosclerotic cardiovascular disease (CVD) prevention. The LDL-C lowering non-statin therapy ezetimibe also modestly reduces CVD risk when added to statin therapy. There remains a clinical need for additional LDL-C lowering agents to reduce CVD risk in patients with genetic hypercholesterolemia, statin intolerance, or who are at high risk due to clinical CVD or diabetes. In clinical trials, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition using monoclonal antibodies has demonstrated robust LDL-C lowering efficacy of 50-65% and a favorable safety profile. These agents are a promising therapeutic strategy for addressing the unmet needs for additional CVD risk reduction. Regulatory approval for PCSK9 monoclonal antibodies may occur in the near future, and additional agents for PCSK9 inhibition are under development. This review focuses on the mechanism of LDL-C reduction using PCSK9 inhibition, as well as the phase I to III clinical trials of PCSK9 inhibitors. Results of the ongoing phase III CVD outcome trials are eagerly awaited." @default.
• W2016063327 created "2016-06-24" @default.
• W2016063327 creator A5009088943 @default.
• W2016063327 creator A5089418361 @default.
• W2016063327 date "2015-07-01" @default.
• W2016063327 modified "2023-10-16" @default.
• W2016063327 title "Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy" @default.
• W2016063327 cites W121888607 @default.
• W2016063327 cites W1252855759 @default.
• W2016063327 cites W158308617 @default.
• W2016063327 cites W161816689 @default.
• W2016063327 cites W162053157 @default.
• W2016063327 cites W1923289550 @default.
• W2016063327 cites W1964279010 @default.
• W2016063327 cites W1965676778 @default.
• W2016063327 cites W1972661406 @default.
• W2016063327 cites W1976252526 @default.
• W2016063327 cites W1983029570 @default.
• W2016063327 cites W1989730880 @default.
• W2016063327 cites W199262836 @default.
• W2016063327 cites W1995187774 @default.
• W2016063327 cites W1998569580 @default.
• W2016063327 cites W2003905161 @default.
• W2016063327 cites W2014561045 @default.
• W2016063327 cites W2023636716 @default.
• W2016063327 cites W2024930123 @default.
• W2016063327 cites W2040612932 @default.
• W2016063327 cites W2064407018 @default.
• W2016063327 cites W2064994526 @default.
• W2016063327 cites W2067539811 @default.
• W2016063327 cites W2078669364 @default.
• W2016063327 cites W2088525830 @default.
• W2016063327 cites W2094133329 @default.
• W2016063327 cites W2096075279 @default.
• W2016063327 cites W2101702589 @default.
• W2016063327 cites W2103007873 @default.
• W2016063327 cites W2103487568 @default.
• W2016063327 cites W2103647780 @default.
• W2016063327 cites W2106285889 @default.
• W2016063327 cites W2108956796 @default.
• W2016063327 cites W2110124859 @default.
• W2016063327 cites W2113170327 @default.
• W2016063327 cites W2118184073 @default.
• W2016063327 cites W2119475560 @default.
• W2016063327 cites W2121581403 @default.
• W2016063327 cites W2127445212 @default.
• W2016063327 cites W2128030263 @default.
• W2016063327 cites W2133043280 @default.
• W2016063327 cites W2138438666 @default.
• W2016063327 cites W2141191772 @default.
• W2016063327 cites W2148577580 @default.
• W2016063327 cites W2151602225 @default.
• W2016063327 cites W2152615674 @default.
• W2016063327 cites W2155259933 @default.
• W2016063327 cites W2156299572 @default.
• W2016063327 cites W2158870651 @default.
• W2016063327 cites W2160761735 @default.
• W2016063327 cites W2160812379 @default.
• W2016063327 cites W2163488353 @default.
• W2016063327 cites W2164324917 @default.
• W2016063327 cites W2165605025 @default.
• W2016063327 cites W2168483013 @default.
• W2016063327 cites W2168536722 @default.
• W2016063327 cites W2168630917 @default.
• W2016063327 cites W2247997571 @default.
• W2016063327 cites W3021842026 @default.
• W2016063327 cites W4236673002 @default.
• W2016063327 cites W4244540230 @default.
• W2016063327 doi "https://doi.org/10.1016/j.pcad.2015.04.004" @default.
• W2016063327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25936907" @default.
• W2016063327 hasPublicationYear "2015" @default.
• W2016063327 type Work @default.
• W2016063327 sameAs 2016063327 @default.
• W2016063327 citedByCount "41" @default.
• W2016063327 countsByYear W20160633272015 @default.
• W2016063327 countsByYear W20160633272016 @default.
• W2016063327 countsByYear W20160633272017 @default.
• W2016063327 countsByYear W20160633272018 @default.
• W2016063327 countsByYear W20160633272019 @default.
• W2016063327 countsByYear W20160633272020 @default.
• W2016063327 countsByYear W20160633272021 @default.
• W2016063327 countsByYear W20160633272022 @default.
• W2016063327 countsByYear W20160633272023 @default.
• W2016063327 crossrefType "journal-article" @default.
• W2016063327 hasAuthorship W2016063327A5009088943 @default.
• W2016063327 hasAuthorship W2016063327A5089418361 @default.
• W2016063327 hasConcept C126322002 @default.
• W2016063327 hasConcept C2776839432 @default.
• W2016063327 hasConcept C2778114629 @default.
• W2016063327 hasConcept C2778163477 @default.
• W2016063327 hasConcept C2778657065 @default.
• W2016063327 hasConcept C2778824825 @default.
• W2016063327 hasConcept C2778849439 @default.
• W2016063327 hasConcept C2780072125 @default.
• W2016063327 hasConcept C2780745583 @default.
• W2016063327 hasConcept C2780902209 @default.
• W2016063327 hasConcept C2780948078 @default.
• W2016063327 hasConcept C43554185 @default.

• next